This also fits our data regarding an unaltered expression of NKG2D, TIGIT and NKG2A on adaptive CD56dim NK cells obtained from HCC patients compared to HD, which have all been reported to be relevant in mediating the anti-tumoral NK cell response [11,12,50,51]. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.